OSUfball

Author Archives

Cytodyn (CYDY) is a stock that was discussed in depth here around 4 years ago. The company makes a monoclonal antibody called leronlimab (formerly known as PRO 140) which is a CCR5 inhibitor for treating HIV. The BLA has been submitted for it and the FDA has granted it fast track designation and a decision […]

Another pitch from Crowdability claiming outlindish 2840% profits per trade using their ”prime profit calendar system” Any idea what it is? It is based on a ”400 year old Dutch document”, any idea what this magical document could be? The pitch is described here: https://www.crowdability.com/article/417-year-old-document-holds-key-to-13233-profits#.XQrBJy2ZMnc

Recent Author Comments

On What's Woods' "$20 Backdoor Bitcoin Trade?"

Yes Hive is good too for the reason you stated that it also mines ETH. All these Canadian miners will get a nice boost in their share price when they list for NASDAQ, which is anticipated sooner than later.[...]

Go to Comment »
On What's Woods' "$20 Backdoor Bitcoin Trade?"

I own many stocks in the cryptocurrency space. I do own Voyager. However, I think the best way to play this space is to own the most undervalued bitcoin miners. The major expense for miners is electricity, which is a fixed cost. However, the price of Bit[...]

Go to Comment »
On Microblog: LexaGene (LXXGF) - Molecular diagnostics company with great upside due to high margin "razor blade" business model

This is old news and was dealt with in the early fall. The cleaning concern was encountered with Covid testing only. Abbott, Thermo Fisher and others all encountered the same issue with not having strong enough disinfectant (there is references for this) [...]

Go to Comment »
On Hodge's pitch: "The first machine in the world that can detect this deadly virus on site is being rushed to market. "

Lexagene is finally no longer just an R&D outfit, but an actual company with a real product. They announced this week the first sale of the MiQLab to a large multinational pharma company. The pharma will be using the MiQLab to test for contaminants in its[...]

Go to Comment »
On What's Basenese's "Hands Down, Perfect" $2 Stock for 5G?

Lou has a pretty good track record on his biotech stock picks. I used to subscribe to one of his paid letters, and get his free email updates now. Regarding 5G, I started tracking all these 5G stocks around the time we cracked the list of 5G stocks Geor[...]

Go to Comment »
On Microblog: D R Barton Dark Edge / dark pool trades - new service 2020

I actually found a free site called aidedtrade (https://www.aidedtrade.io). Just click the "X" on the subscribe now popup that appears. 100% free and no registration or free trial nonsense.[...]

Go to Comment »
On Doc Gumshoe – COVID-19 Miscellany, May 2020

The yahoo finance message board for Cytodyn (CYDY), the company that owns leronlimab, is a good source of the latest info.[...]

Go to Comment »
On Microblog: D R Barton Dark Edge / dark pool trades - new service 2020

There are screeners that you can pay a monthly fee and get this info. FlowAlgo (http://flowalgo.com) is an example of one. I would not pay any guru to feed me this info as he or she is probably front running the info.[...]

Go to Comment »
On Microblog: Optional Alpha

You might learn something about options, but you probably won't make money as is the case by following most of these gurus. Here is a review about his service: https://www.youtube.com/watch?v=a9HMwk8pnHc&t=650s[...]

Go to Comment »
On De-teasing Gilder's "Don't buy 5G Stocks, Buy 15G Instead" pitch

Also wanted to say that I've been reading this site since it was founded and I'm a lifetime irregulars member. Travis you've saved me thousands by preventing me from subscribing to all these newsletters. So heartfelt thanks for all you do here.[...]

Go to Comment »
On De-teasing Gilder's "Don't buy 5G Stocks, Buy 15G Instead" pitch

Not Gilder 5G stocks, but two that I like in this space are Atomera (ATOM) and Lumentum (LITE). Atomera is small cap while Lumentum isn't and had a nice run up last year.[...]

Go to Comment »
On What's Bonner's "FDA Fast Tracks $6.8 Billion Miracle Antibiotic" pitch about?

Unfortunately bought AKAO and learned my lesson. Never again will I buy a biotech company developing an antibiotic. There simply isn't enough profit potential even if the drug is approved.[...]

Go to Comment »
On Microblog: George Gilder's DON'T BUY 5G stocks. BUY ‘15G’ instead

What I hate the most is these guys sell a "basic" newsletter (and you don't know its their basic version) and you get a pitch later on for the expensive newsletter where presumably the best investing ideas are located. You expect someone to give you their [...]

Go to Comment »
On Microblog: George Gilders Moonshots six tech stocks

It's here: https://www.stockgumshoe.com/2020/04/microblog-george-gilders-dont-buy-5g-stocks-buy-15g-instead/[...]

Go to Comment »
On Microblog: George Gilder's DON'T BUY 5G stocks. BUY ‘15G’ instead

Here are my guesses for far listed in the order in which he talks about them: 2. "Makes the sensors for self-driving cars" - Ambarella (AMBA) 3. "Merges AI and network security" - A10 Networks (ATEN) 6. "Safeguards the internet of things" - Allot (ALLT[...]

Go to Comment »
On Microblog: Any idea what "THE MOTLEY FOOL'S NO. 1 TECHNOLOGY INVESTMENT FOR THE 2020s" might be?

It's obvious that these days for the Motley Fool itself, selling newsletters is the #1 investment. Rather disappointing, because in the mid 90's when the Gardner brothers first wrote their book they seemed more interested in educating the public and financ[...]

Go to Comment »
On Microblog: DYLAN JOVINE #1 TAKEOVER TARGET FOR APRIL

MEI Pharma (MEIP). It was not hard for me to figure out with the clues he gave, most notably, MEI received FDA fast track approval in early April for its lymphoma drug and recently received a $100M investment from a foreign pharma.[...]

Go to Comment »
On Microblog: Dylan Jovine claims the next big biotech takeover in 2020 will be a" Cut and Paste" company

The email blast he's been sending out this month for a cancer company treating lymphoma that "could save your life" is MEI Pharma (MEIP). It was not hard for me to figure out with the clues he gave, most notably, MEI received FDA fast track approval in ear[...]

Go to Comment »
On What's Teased as "Our #1 Takeover Target for February?"

I figured out Jovine's April takeover candidate. It's MEI Pharma (MEIP). This company is developing a drug for lymphoma. Currently (as of 4/18/20) trading at $2.42, so the 2.50 June and Sep call options look intriguing. MEI recently received a $100M invest[...]

Go to Comment »
On Microblog: Dylan Jovine's Next Takeover Target (Behind The Markets newsletter)

I got his email yesterday about the "#1 takeover target for April." He gave some clues suchs as this company is going to cure lymphoma, got FDA fast track approval 2 weeks ago, and recently received a $100M investment from a foreign corporation. I put all [...]

Go to Comment »

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info